Author/Authors :
Jafarzadeh ، A نويسنده Professor, Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Jafarzadeh , A , Shabani ، Z نويسنده Assistant Prof., Immunology of Infectious Diseases Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Shabani , Z , Hassanabadi ، M نويسنده - Student in Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Hassanabadi , M , Rezayati ، MT نويسنده Expert in Molecular Medicine Research Center, Rafsanjan University of Medical Sciences, Rafsanjan, Iran. Rezayati , MT , Nemati ، M نويسنده Expert in Dept. of Microbiology and Immunology, Medical of School, Kerman University of Medical Sciences, Kerman, Iran. Nemati , M , Sayadi ، AR نويسنده Faculty member, Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan-Iran. Sayadi , AR , Sheikhi ، A نويسنده Associate Prof., Dept. of Immunology, Medical of School, Dezful University of Medical Sciences, Dezful, Iran. Sheikhi , A , Vazirinejad ، R نويسنده Professor, Social Determinants of Health Research Center, Rafsanjan University of Medical Sciences, Rafsanjan-Iran. Vazirinejad , R
Abstract :
Background: Cigarette smoking has been linked with the suppression of immune responses and increased susceptibility to numerous infections in humans. Tetanus is also a major public health problem in many countries. The aim of the present study was to evaluate the serum levels of anti-tetanus toxin antibodies in cigarette smoking and healthy non-smoking people.
Materials and Methods: A total of 100 cigarette smokers and 100 age-matched healthy non-smoker individuals were enrolled in this descriptive study. A blood sample was collected from each participant. The samples were tested for the levels of anti-tetanus toxin antibodies by use of enzyme linked immunosorbent assay.
Results: The seroprotective rate of anti-tetanus toxin antibodies in non-smoking group (99%) was significantly higher than that observed in cigarette smoking group (78%, P < 0.0001). The mean titer of anti-tetanus toxin antibodies in non-smoking group (5.32± 0.26 IU/ml) was also significantly higher than that in smoker subjects (1.03 ± 0.16 IU/ml; P < 0.0001). The mean titer of anti-tetanus toxin antibodies in individuals with smoking duration > 10 years was significantly lower than that among smokers with smoking duration ?10 years (0.59 ± 0.12 IU/ml vs 1.98 ± 0.41 IU/ml; P < 0.001). The seroprotection rate was also significantly lower in persons with smoking duration > 10 years in comparison to smokers with smoking duration ?10 years (72.1% vs 90.6%; P=0.037). The mean titer of anti-tetanus toxin antibodies in individuals with daily smoking > 10 cigarettes was also significantly lower in comparison to smokers with daily smoking ?10 cigarettes (0.68 ± 0.15 IU/ml vs 1.63 ± 0.36 IU/ml; P < 0.001).
Conclusion: These results showed lower levels of anti-tetanus toxin antibodies in cigarette smokers which represents cigarette smoking as a risk factor for susceptibility to tetanus. A negative association was also observed between the immunity to tetanus and smoking burden.
